全文获取类型
| 收费全文 | 5767篇 |
| 免费 | 535篇 |
| 国内免费 | 116篇 |
专业分类
| 耳鼻咽喉 | 44篇 |
| 儿科学 | 151篇 |
| 妇产科学 | 250篇 |
| 基础医学 | 719篇 |
| 口腔科学 | 76篇 |
| 临床医学 | 599篇 |
| 内科学 | 1138篇 |
| 皮肤病学 | 107篇 |
| 神经病学 | 441篇 |
| 特种医学 | 400篇 |
| 外科学 | 763篇 |
| 综合类 | 179篇 |
| 预防医学 | 331篇 |
| 眼科学 | 103篇 |
| 药学 | 426篇 |
| 中国医学 | 26篇 |
| 肿瘤学 | 665篇 |
出版年
| 2023年 | 32篇 |
| 2022年 | 55篇 |
| 2021年 | 129篇 |
| 2020年 | 99篇 |
| 2019年 | 180篇 |
| 2018年 | 181篇 |
| 2017年 | 123篇 |
| 2016年 | 144篇 |
| 2015年 | 187篇 |
| 2014年 | 224篇 |
| 2013年 | 330篇 |
| 2012年 | 377篇 |
| 2011年 | 383篇 |
| 2010年 | 275篇 |
| 2009年 | 219篇 |
| 2008年 | 302篇 |
| 2007年 | 307篇 |
| 2006年 | 279篇 |
| 2005年 | 284篇 |
| 2004年 | 259篇 |
| 2003年 | 219篇 |
| 2002年 | 212篇 |
| 2001年 | 182篇 |
| 2000年 | 152篇 |
| 1999年 | 155篇 |
| 1998年 | 79篇 |
| 1997年 | 77篇 |
| 1996年 | 64篇 |
| 1995年 | 49篇 |
| 1994年 | 34篇 |
| 1993年 | 46篇 |
| 1992年 | 88篇 |
| 1991年 | 81篇 |
| 1990年 | 59篇 |
| 1989年 | 63篇 |
| 1988年 | 59篇 |
| 1987年 | 58篇 |
| 1986年 | 47篇 |
| 1985年 | 61篇 |
| 1984年 | 44篇 |
| 1983年 | 27篇 |
| 1982年 | 26篇 |
| 1981年 | 19篇 |
| 1980年 | 14篇 |
| 1979年 | 12篇 |
| 1978年 | 20篇 |
| 1977年 | 14篇 |
| 1975年 | 15篇 |
| 1974年 | 11篇 |
| 1969年 | 9篇 |
排序方式： 共有6418条查询结果，搜索用时 15 毫秒
981.
982.
Chen BB Shih TT Hsu CY Yu CW Wei SY Chen CY Wu CH Chen CY 《The journal of nutrition, health & aging》2011,15(6):433-438
Objectives
1) to correlate thigh muscle volume measured by magnetic resonance image (MRI) with anthropometric measurements and physical function in elderly subjects; 2) to predict MRI-measured thigh muscle volume using anthropometric measurements and physical functional status in elderly subjects. 相似文献983.
Andrea J. Radtke Evelyn Kandov Bradley Lowekamp Emily Speranza Colin J. Chu Anita Gola Nishant Thakur Rochelle Shih Li Yao Ziv Rafael Yaniv Rebecca T. Beuschel Juraj Kabat Joshua Croteau Jeremy Davis Jonathan M. Hernandez Ronald N. Germain 《Proceedings of the National Academy of Sciences of the United States of America》2020,117(52):33455
984.
985.
S. Kim M.J. Graham R.G. Lee L. Yang S. Kim V. Subramanian J.D. Layne L. Cai R.E. Temel D. Shih A.J. Lusis J.A. Berliner S. Lee 《Nutrition, metabolism, and cardiovascular diseases : NMCD》2019,29(3):306-315
Background and aims
Heparin-binding EGF-like growth factor (HB-EGF) is a representative EGF family member that interacts with EGFR under diverse stress environment. Previously, we reported that the HB-EGF-targeting using antisense oligonucleotide (ASO) effectively suppressed an aortic aneurysm in the vessel wall and circulatory lipid levels. In this study, we further examined the effects of the HB-EGF ASO administration on the development of hyperlipidemia-associated atherosclerosis using an atherogenic mouse model.Methods and results
The male and female LDLR deficient mice under Western diet containing 21% fat and 0.2% cholesterol content were cotreated with control and HB-EGF ASOs for 12 weeks. We observed that the HB-EGF ASO administration effectively downregulated circulatory VLDL- and LDL-associated lipid levels in circulation; concordantly, the HB-EGF targeting effectively suppressed the development of atherosclerosis in the aorta. An EGFR blocker BIBX1382 administration suppressed the hepatic TG secretion rate, suggesting a positive role of the HB-EGF signaling for the hepatic VLDL production. We newly observed that there was a significant improvement of the insulin sensitivity by the HB-EGF ASO administration in a mouse model under the Western diet as demonstrated by the improvement of the glucose and insulin tolerances.Conclusion
The HB-EGF ASO administration effectively downregulated circulatory lipid levels by suppressing hepatic VLDL production rate, which leads to effective protection against atherosclerosis in the vascular wall. 相似文献986.
987.
Bo Yang Elizabeth L. Norton Terry Shih Linda Farhat Xiaoting Wu Whitney E. Hornsby Karen M. Kim Himanshu J. Patel G. Michael Deeb 《The Journal of thoracic and cardiovascular surgery》2019,157(4):1313-1321.e2
Objective
To compare perioperative and long-term outcomes in patients undergoing hemiarch and aggressive arch replacement for acute type A aortic dissection (ATAAD).Methods
From 1996 to 2017, we compared outcomes of hemiarch (n = 322) versus aggressive arch replacements (zones 2 and 3 arch replacement with implantation of 2-4 arch branches, n = 150) in ATAAD. Indications for aggressive arch were arch aneurysm >4 cm or intimal tear in the aortic arch that was not resectable by hemiarch replacement, or dissection of arch branches with malperfusion.Results
Patients in the aggressive arch group were significantly younger (mean age: 57 vs 61 years old) and had significantly longer hypothermic circulatory arrest, cardiopulmonary bypass, and aortic crossclamp times. There were no significant differences in perioperative outcomes between hemiarch and aggressive arch groups, including 30-day mortality (5.3% vs 7.3%, P = .38) and postoperative stroke rate (7% vs 7%, P = .96). Over 15 years, Kaplan–Meier survival was similar between hemiarch and aggressive arch groups (log-rank P = .55, 10-year survival 70% vs 72%). Given death as a competing factor, incidence rates of reoperation over 15 years (2.1% vs 2.0% per year, P = 1) and 10-year cumulative incidence of reoperation (14% vs 12%, P = .89) for arch and distal aorta pathology were similar between the 2 groups.Conclusions
Both hemiarch and aggressive arch replacement are appropriate approaches for select patients with ATAAD. Aggressive arch replacement should be considered for an arch aneurysm >4 cm or an intimal tear at the arch unable to be resected by hemiarch replacement, or dissection of the arch branches with malperfusion. 相似文献988.
989.
990.
Wen-Shiuan Shih Chueh-Hung Wu Tyng-Guey Wang 《Journal of Science and Medicine in Sport》2019,22(4):392-396